跳至主要内容
临床试验/NL-OMON40961
NL-OMON40961已完成不适用

Characterisation of neurotransmitter network dysfunction in MRI-negative localisation-related epilepsy - Neurotransmitter network dysfunction in epilepsy

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Subjects must be older than 18 years and able to give informed consent. ;Epilepsy patients:
  • - Diagnosed with cryptogenic localization-related epilepsy with an epileptic focus in the frontal or temporal lobe (using EEG)
  • - Seizure frequency below 13/year.
  • - No changes in anti-epileptic drugs (medication or dose) in the last 6 months.

排除标准

  • - MRI visible lesions, as seen on the clinical 3T scans
  • - All absolute or relative contraindications for MR scanning.
  • - A medical history with cerebral diseases (other than epilepsy), vascular problems, diabetes mellitus, hypertension and/or cerebral surgery.

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验